NLM Digital Collections

Search

Start Over Collections Health Policy and Services Research ✖Remove constraint Collections: Health Policy and Services Research Subjects United States ✖Remove constraint Subjects: United States Genre Technical Report ✖Remove constraint Genre: Technical Report Copyright Public domain ✖Remove constraint Copyright: Public domain

152. Key design components and considerations for establishing a single-payer health care system: testimony before the Committee on the Budget, United States House of Representatives

Publication:
[Washington, DC] : Congressional Budget Office, May 22, 2019
Subject(s):
Insurance, Health, Reimbursement
Single-Payer System -- organization & administration
Universal Health Insurance
Cost Sharing
Health Care Reform
Health Services Accessibility
Insurance Coverage
Insurance, Health -- organization & administration
Humans
United States

153. Federal mandatory spending for means-tested programs: 2009 to 2029

Publication:
[Washington, DC] : Congressional Budget Office, June 2019
Subject(s):
Financing, Government -- economics
Financing, Government -- trends
Mandatory Programs -- economics
Mandatory Programs -- trends
Public Assistance -- economics
Public Assistance -- trends
Budgets
Eligibility Determination
Forecasting
Income
Government Programs -- economics
Government Programs -- trends
Humans
United States

155. Projecting demand for the services of primary care doctors:

Author(s):
Duchovny, Noelia, author
Trachtman, Sam, author
Werble, Ellen, author
Publication:
Washington, D.C. : Congressional Budget Office, May 2017
Subject(s):
Health Services Needs and Demand -- statistics & numerical data
Physicians, Family -- supply & distribution
Primary Health Care -- statistics & numerical data
Primary Health Care -- trends
Federal Government
Forecasting
Health Manpower -- statistics & numerical data
Health Manpower -- trends
Health Policy
Health Services Needs and Demand -- trends
Insurance Coverage
Insurance, Health, Reimbursement
Medicaid
Medicare
Physicians, Family -- education
Population Dynamics
Population Growth
Telemedicine
Humans
United States

157. An analysis of private-sector prices for hospital admissions

Author(s):
Maeda, Jared Lane, author
Nelson, Lyle, author
Publication:
[Washington, D.C.] : Congressional Budget Office, April 2017
Subject(s):
Hospital Costs -- statistics & numerical data
Insurance, Health, Reimbursement
Medicare -- economics
Medicare Part C -- economics
Private Sector
Diagnosis-Related Groups
Fee-for-Service Plans -- economics
Health Expenditures -- statistics & numerical data
Reimbursement Mechanisms
Humans
United States

158. Food Safety: a national strategy is needed to address fragmentation in federal oversight : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, January 2017
Subject(s):
Food Safety
Food Supply
Government Regulation
Interinstitutional Relations
Federal Government
Public Health
Humans
United States
United States. Department of Agriculture.
United States. Food and Drug Administration.

159. Medicaid: CMS needs better data to monitor the provision of and spending on personal care services : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, January 2017
Subject(s):
Community Health Services -- economics
Data Collection
Health Expenditures
Home Care Services -- economics
Long-Term Care -- economics
Medicaid -- economics
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

160. Medicaid managed care: improved oversight needed of payment rates for long-term services and supports : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, January 2017
Subject(s):
Community Health Services -- economics
Insurance, Health, Reimbursement -- economics
Long-Term Care -- economics
Managed Care Programs -- economics
Medicaid -- economics
Data Collection
Government Regulation
State Government
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

161. Foster care: HHS has taken steps to support states' oversight of psychotropic medications, but additional assistance could further collaboration : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, January 2017
Subject(s):
Child Welfare
Drug Utilization -- statistics & numerical data
Foster Home Care
Inappropriate Prescribing -- prevention & control
Psychotropic Drugs -- therapeutic use
Child
Government Regulation
Information Dissemination
Interinstitutional Relations
State Government
Humans
United States
United States. Department of Health and Human Services.

163. Defense civil support: DOD, HHS, and DHS should use existing coordination mechanisms to improve their pandemic preparedness : report to the Committee on Armed Services, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, February 2017
Subject(s):
Civil Defense
Interinstitutional Relations
Pandemics
Disaster Planning
Federal Government
Humans
United States
United States. Department of Defense.
United States. Department of Health and Human Services.
United States. Department of Homeland Security.

164. Medical devices: cancer risk led FDA to warn against certain uses of power morcellators and recommend new labeling : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, February 2017
Subject(s):
Device Approval
Equipment Safety
Morcellation -- adverse effects
Morcellation -- instrumentation
Product Labeling
Leiomyoma -- surgery
Uterine Neoplasms -- surgery
Humans
United States
United States. Food and Drug Administration

165. Drug-free community support program: agencies have strengthened collaboration but could enhance grantee compliance and performance monitoring : report to Congressional committees

Publication:
Washington, D.C. : U.S. Government Accountability Office, February 2017
Subject(s):
Community Health Services
Community-Institutional Relations
Interinstitutional Relations
Substance-Related Disorders -- prevention & control
Adolescent
Financing, Government
Guideline Adherence
Humans
United States
United States. Department of Health and Human Services.

167. The effects of terminating payments for cost-sharing reductions

Publication:
Washington, D.C. : Congressional Budget Office, 2017
Subject(s):
Cost Sharing -- economics
Deductibles and Coinsurance -- economics
Health Insurance Exchanges -- economics
Insurance Coverage -- statistics & numerical data
Insurance, Health -- statistics & numerical data
Budgets
Federal Government
Income Tax
Poverty
Humans
United States
United States.

168. Out-of-pocket expenditures for adults with health care expenses for multiple chronic conditions, U.S. civilian noninstitutionalized population, 2014

Author(s):
Soni, Anita, author
Publication:
Rockville, MD : Agency for Healthcare Research and Quality, February 2017
Subject(s):
Chronic Disease -- economics
Comorbidity
Health Expenditures -- statistics & numerical data
Adult
Aged
Continental Population Groups
Ethnic Groups
Health Care Surveys
Income
Insurance Coverage
Insurance, Health
Humans
United States
Medical Expenditure Panel Survey (U.S.)

169. Trends in enrollment, offers, eligibility and take-up for employer-sponsored insurance: private sector, by state Medicaid expansion status, 2008-2015

Author(s):
Cooper, Phil, author
Davis, Karen, author
Miller, G. Edward, author
Publication:
Rockville, MD : Agency for Healthcare Research and Quality, February 2017
Subject(s):
Eligibility Determination
Health Benefit Plans, Employee -- statistics & numerical data
Health Benefit Plans, Employee -- trends
Health Benefit Plans, Employee -- utilization
Medicaid
Forecasting
Health Care Surveys
Private Sector
State Government
Humans
United States
United States.
Medical Expenditure Panel Survey (U.S.)

170. Emergency use authorization of medical products and related authorities: guidance for industry and other stakeholders

Publication:
Silver Spring, MD : Food and Drug Administration, U.S. Department of Health and Human Services, January 2017
Subject(s):
Civil Defense -- legislation & jurisprudence
Device Approval
Drug Approval
Emergencies
Terrorism
Emergency Medical Services
Equipment Safety
Off-Label Use
Public Health
Safety
Humans
United States
United States. Department of Health and Human Services.
United States. Department of Homeland Security.
United States. Food and Drug Administration.

171. Form FDA 3674--certifications to accompany drug, biological product, and device applications/submissions: guidance for sponsors, industry, researchers, investigators, and food and drug administration staff

Publication:
Silver Spring, MD : Food and Drug Administration, U.S. Department of Health and Human Services, June 2017
Subject(s):
Device Approval
Drug Approval
Investigational New Drug Application
Access to Information
Clinical Trials as Topic
Drugs, Investigational
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

172. E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs--questions and answers (R3)

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, June 2017
Subject(s):
Arrhythmias, Cardiac -- chemically induced
Arrhythmias, Cardiac -- diagnosis
Cardiac Electrophysiology -- methods
Cardiac Electrophysiology -- standards
Drug Approval
Electrocardiography -- standards
Long QT Syndrome -- chemically induced
Cardiotoxins
Clinical Trials as Topic
Congresses as Topic
Diagnosis, Computer-Assisted
Drug-Related Side Effects and Adverse Reactions
International Cooperation
Pharmaceutical Preparations -- administration & dosage
Reference Standards
Research Design
Sex Factors
Humans
Europe
Japan
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

174. IRB waiver or alteration of informed consent for clinical investigations involving no more than minimal risk to human subjects: guidance for sponsors, investigators, and institutional review boards

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, July 2017
Subject(s):
Clinical Trials as Topic -- standards
Human Experimentation -- standards
Informed Consent -- standards
Ethics Committees, Research
Ethics, Research
Informed Consent -- ethics
Research Subjects
Risk
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

176. Federal subsidies for health insurance coverage for people under age 65: 2017 to 2027

Publication:
Washington, D.C. : Congressional Budget Office, September 2017
Subject(s):
Cost Sharing -- statistics & numerical data
Cost Sharing -- trends
Insurance Coverage -- statistics & numerical data
Insurance Coverage -- trends
Insurance, Health -- statistics & numerical data
Insurance, Health -- trends
Adult
Child
Child Health Services
Federal Government
Forecasting
Health Benefit Plans, Employee
Infant
Medicaid
Medically Uninsured -- statistics & numerical data
Medicare
Middle Aged
State Government
Humans
United States
United States.
State Children's Health Insurance Program (U.S.)

177. Consumer antiseptic wash final rule: questions and answers : (Small Entity Compliance Guide)

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, July 2017
Subject(s):
Anti-Infective Agents, Local
Consumer Product Safety
Hand Sanitizers
Nonprescription Drugs
Anti-Bacterial Agents
Anti-Infective Agents, Local -- adverse effects
Soaps
Triclosan
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

178. Generic Drug User Fee Amendments of 2012: questions and answers related to self-identification of facilities, review of generic drug submissions, and inspections and compliance

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, July 2017
Subject(s):
Drug Approval
Drug Industry -- standards
Drugs, Generic
Guideline Adherence
Investigational New Drug Application
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

179. Antibacterial therapies for patients with an unmet medical need for the treatment of serious bacterial diseases

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, August 2017
Subject(s):
Anti-Bacterial Agents -- therapeutic use
Bacterial Infections -- drug therapy
Drug Approval
Drug Resistance, Bacterial
Investigational New Drug Application
Clinical Trials as Topic
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

180. FY 2018 medical device user fee small business qualification and certification: guidance for industry, Food and Drug Administration staff and foreign governments

Publication:
Silver Spring, MD : Center for Devices and Radiological Health, August 29, 2017
Subject(s):
Device Approval
Small Business
Eligibility Determination
Taxes
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

181. Use of real-world evidence to support regulatory decision-making for medical devices: guidance for industry and Food and Drug Administration staff

Publication:
Silver Spring, MD : Center for Devices and Radiological Health, August 31, 2017
Subject(s):
Equipment and Supplies
Equipment Safety
Evidence-Based Medicine
Product Surveillance, Postmarketing
Data Collection
Data Interpretation, Statistical
Decision Making
Device Approval
Quality Control
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

182. Procedures for meetings of the Medical Devices Advisory Committee: guidance for industry and Food and Drug Administration staff

Publication:
Silver Spring, MD : Center for Devices and Radiological Health, September 1, 2017
Subject(s):
Advisory Committees -- organization & administration
Device Approval
Equipment and Supplies -- classification
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

183. Design considerations and pre-market submission recommendations for interoperable medical devices: guidance for industry and Food and Drug Administration staff

Publication:
Silver Spring, MD : Center for Devices and Radiological Health, September 6, 2017
Subject(s):
Equipment and Supplies -- standards
Equipment Design -- standards
Equipment Safety -- standards
Device Approval
Equipment Failure
Information Dissemination
Risk Management
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

184. Evaluation and reporting of age-, race-, and ethnicity-specific data in medical device clinical studies: guidance for Industry and Food and Drug Administration staff

Publication:
Silver Spring, MD : Center for Devices and Radiological Health, September 12, 2017
Subject(s):
Clinical Trials as Topic
Demography
Device Approval
Research Design
Age Factors
Continental Population Groups
Ethnic Groups
Product Surveillance, Postmarketing
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

185. Establishing the performance characteristics of in vitro diagnostic devices for the detection or detection and differentiation of human papillomaviruses: guidance for Industry and Food and Drug Administration staff

Publication:
Silver Spring, MD : Center for Devices and Radiological Health, September 15, 2017
Subject(s):
Device Approval
Papillomavirus Infections -- diagnosis
Reagent Kits, Diagnostic -- standards
Cervix Uteri -- cytology
Cervix Uteri -- virology
Equipment Failure
Equipment Safety
Genotyping Techniques -- standards
Mass Screening
Papillomaviridae -- classification
Papillomaviridae -- genetics
Quality Control
Reference Standards
Reproducibility of Results
Research Design
Specimen Handling
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

186. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 1(R1) : residue on ignition/sulphated ash general chapter

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, September 2017
Subject(s):
Chemistry, Pharmaceutical
Drug Approval
Pharmacopoeias as Topic -- standards
Congresses as Topic
International Cooperation
Sulfur
Humans
Europe
Japan
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

187. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 2(R1) : test for extractable volume of parenteral preparations general chapter

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, September 2017
Subject(s):
Chemistry, Pharmaceutical
Drug Approval
Pharmacopoeias as Topic -- standards
Congresses as Topic
Infusions, Parenteral
International Cooperation
Humans
Europe
Japan
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

188. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 3(R1) : test for particulate contamination : subvisible particles general chapter

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, September 2017
Subject(s):
Drug Approval
Drug Contamination
Particulate Matter
Pharmacopoeias as Topic -- standards
Congresses as Topic
International Cooperation
Humans
Europe
Japan
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

189. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 4A(R1) : microbiological examination of nonsterile products : microbial enumeration tests general chapter

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, September 2010
Subject(s):
Drug Approval
Microbiological Techniques -- standards
Pharmacopoeias as Topic -- standards
Congresses as Topic
International Cooperation
Humans
Europe
Japan
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

190. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 4B(R1) : microbiological examination of nonsterile products : tests for specified microorganisms general chapter

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, September 2017
Subject(s):
Drug Approval
Microbiological Techniques -- standards
Pharmacopoeias as Topic -- standards
Congresses as Topic
International Cooperation
Humans
Europe
Japan
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

191. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 4C(R1) : microbiological examination of nonsterile products : acceptance criteria for pharmaceutical preparations and substances for pharmaceutical use general chapter

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, September 2017
Subject(s):
Drug Approval
Microbiological Techniques -- standards
Pharmacopoeias as Topic -- standards
Congresses as Topic
International Cooperation
Humans
Europe
Japan
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

192. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 5(R1) : disintegration test general chapter

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, September 2017
Subject(s):
Chemistry, Pharmaceutical -- standards
Drug Approval
Pharmacopoeias as Topic -- standards
Capsules
Congresses as Topic
International Cooperation
Tablets
Humans
Europe
Japan
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

193. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 9(R1) : tablet friability general chapter

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, September 2017
Subject(s):
Chemistry, Pharmaceutical -- standards
Drug Approval
Pharmacopoeias as Topic -- standards
Congresses as Topic
International Cooperation
Tablets
Humans
Europe
Japan
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

194. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 10(R1) : polyacrylamide gel electrophoresis general chapter

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, September 2017
Subject(s):
Drug Approval
Pharmacopoeias as Topic -- standards
Congresses as Topic
Electrophoresis, Polyacrylamide Gel
International Cooperation
Humans
Europe
Japan
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

195. Antibiotics: FDA has encouraged development, but needs to clarify the role of draft guidance and develop qualified infectious disease product guidance : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, January 2017
Subject(s):
Anti-Bacterial Agents -- therapeutic use
Drug Approval
Drug Industry
Drugs, Investigational
Investigational New Drug Application
Drug Resistance, Bacterial
Guidelines as Topic
Humans
United States
United States. Food and Drug Administration.

196. Workplace safety and health: information on OSHA training for workers on workplace hazards : report to the Chairman, Subcommittee on Health, Employment, Labor, and Pensions, Committee on Education and the Workforce, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, February 2017
Subject(s):
Inservice Training
Occupational Health -- education
Documentation
Fraud -- prevention & control
Safety
Humans
United States
United States. Occupational Safety and Health Administration.

197. Health information technology: HHS should assess the effectiveness of its efforts to enhance patient access to and use of electronic health information : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, March 2017
Subject(s):
Access to Information
Electronic Health Records
Medicare
Government Programs
Patient Participation
Program Evaluation
Humans
United States
United States. Department of Health and Human Services.

198. Antibiotic resistance: more information needed to oversee use of medically important drugs in food animals : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, March 2017
Subject(s):
Anti-Bacterial Agents -- adverse effects
Anti-Bacterial Agents -- therapeutic use
Bacterial Infections -- drug therapy
Drug Resistance, Bacterial
Drug Resistance, Microbial
Food -- adverse effects
Food Inspection
Food Safety
Foodborne Diseases -- microbiology
Veterinary Drugs -- adverse effects
Veterinary Drugs -- therapeutic use
Bacterial Infections -- epidemiology
Cattle
Disease Outbreaks -- prevention & control
Foodborne Diseases -- epidemiology
Poultry
Swine
World health
Humans
Canada
Denmark
Netherlands
United States
United States. Department of Agriculture.
United States. Department of Health and Human Services.

199. VA disability benefits: additional planning would enhance efforts to improve the timeliness of appeals decisions : report to Congressional addressees

Publication:
Washington, D.C. : U.S. Government Accountability Office, 2017
Subject(s):
Health Manpower
Insurance Claim Review
Veterans Disability Claims
Workload
Disabled Persons
Personnel Staffing and Scheduling
Veterans
Humans
United States
United States. Department of Veterans Affairs.

200. Medicare provider education: oversight of efforts to reduce improper billing needs improvement : report to the Chairman, Committee on Finance, U.S. Senate

Publication:
Washington, D.C. : U.S. Government Accountability Office, March 2017
Subject(s):
Accounts Payable and Receivable
Fraud -- prevention & control
Insurance Claim Review
Medicare -- economics
Contract Services
Insurance, Health, Reimbursement
Humans
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

Refine by:

more »

more »

more »

Current results range from 2006 to 2024